Individuals with Medicare Advantage plans have lower hospitalization rates than those with traditional fee-for-service Medicare plans.
Individuals with Medicare Advantage (MA) plans have lower hospitalization rates than those with traditional fee-for-service Medicare (TM) plans, according to a study from Robert Graham Center.
Although earlier studies have indicated this trend before, the results have not always been interpreted in similar ways. Proponents of MA plans, for instance, see lower hospitalization rates as evidence of better care management, with an especial focus on preventive services and primary care. Those opposed to MA plans argue that these lower rates show a selection bias that tends towards healthier enrollees, or else can be attributed to other external factors.
A team of researchers, led by Stephen Petterson, PhD, reviewed hospital utilization data from the Healthcare Cost and Utilization Project (HCUP) for 12 states in order to compare the effects of MA plans on hospitalizations versus TM plans. Hospitalizations were sorted as avoidable hospitalizations, or those that could have been avoided with better outpatient care; hospitalizations for marker conditions, or those that could not have been avoided by better outpatient care; and referral-sensitive hospitalizations, those that were planned to avoid a worse outcome.
Their sample included just over 3 million discharges, of patients 65 years and older whose primary payer was Medicare. Data was from 2012 or 2013, depending on what was the most recent available as of September 2015. States included were Arizona, Florida, Iowa, Kentucky, Massachusetts, Maryland, Michigan, New Jersey, Nevada, Oregon, Rhode Island, and Wisconsin because their data differentiated between MA and TM plans.
The authors concluded that MA plans reduced avoidable hospitalizations by approximately 10%, even accounting for age, gender, race/ethnicity, region, and other health proxies. Their sample also depicted TM beneficiaries with a 31% higher rate of hospitalizations than MA beneficiaries. In addition, TM beneficiaries’ rates for marker conditions were higher than MA beneficiaries. Enrollees with MA plans were approximately 6% more likely than TM enrollees to have referral-sensitive hospitalizations—typically a sign of better outpatient care.
Researchers also noticed a “spillover effect” on TM beneficiaries. That is, “counties with higher MA penetration rates have fewer avoidable hospitalizations for both MA enrollees and TM beneficiaries, even after controlling for other explanatory factors. In addition, higher MA penetration rates increase referral-sensitive hospitalizations.”
The team recommends further study to account for this effect and see if it is related to payment incentives that promote efficiency, coordination, and primary care with the treatment of MA individuals.
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More
PAH Therapies Improve Outcomes in PH-ILD
March 26th 2025Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among individuals who have idiopathic pulmonary fibrosis. Overall, most cases of PH in the setting of ILD are mild.
Read More